Single Dosing Clinical Trial of HL151

NCT02682745 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis, Allergic, Perennial

Interventions

DRUG: HL151
DRUG: TALION tab.

Sponsor

Hanlim Pharm. Co., Ltd.